Bell2Bell’s latest podcast features Matt Stang, CEO of Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform committed to bringing science-backed benefits to all and reframing the psychedelic conversation.

Throughout the interview, Stang discussed the Delic ecosystem of businesses and examined how psychedelic research is driving a paradigm shift in the treatment of mental health.

“Delic is the world’s first psychedelic wellness corporation. We have three different businesses, but they all create this amazing ecosystem,” Stang said. “We have the largest chain of psychedelic wellness clinics in America, with 12 clinics operational today under the Ketamine Wellness Centers and Ketamine Infusion Centers brands. We have Delic Labs, a Health Canada-licensed lab in Vancouver with licenses to do scientific research around cannabis, hemp and psychedelics, doing work for major companies across the space. And we have a media and events platform. I just came back from the largest psychedelic event in America; it’s called Meet Delic. We had our first year; we had over 2,500 people in attendance and some incredible names speaking. Then, we have a media platform called Reality Sandwich, which gets a couple hundred thousand people a month looking for information about psychedelics.”